nding at
December 31, 2008 and 2007,
respectively) 42,420 41,794
Additional paid-in capital 11,554,381 8,095,848
Statutory reserves 3,750,529 2,161,505
Retained earnings 25,557,537 14,355,913
Other comprehensive gain -
cumulative foreign currency
translation adjustment 4,229,243 1,981,557
Total Shareholders' Equity 45,134,110 26,636,617
Total Liabilities and
Shareholders' Equity $63,708,518 $36,899,533
LOTUS PHARMACEUTICALS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Year Ended
December 31,
2008 2007
NET REVENUES:
Wholesale $65,264,281 $41,651,106
Retail 2,837,257 3,471,960
Other revenues 5,701,491 11,750,049
Total Net Revenues 73,803,029 56,873,115
COST OF SALES 40,440,088 33,678,963
GROSS PROFIT 33,362,941 23,194,152
OPERATING EXPENSES:
Selling expenses 14,902,646 6,460,206
Research and development 1,200,194 2,411,651
General and administrative 2,190,157 3,014,002
Total Operating Expenses 18,292,997 11,885,859
INCOME FROM OPERATIONS 15,069,944 11,308,293
OTHER INCOME (EXPENSE):
'/>"/>SOURCE Lotus Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related medicine news :1.
iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software2.
Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug3.
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs4.
Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference5.
Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results6.
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 20087.
Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results8.
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg9.
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results10.
Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results11.
Lotus Pharmaceuticals Raises $5 Million in Private Placement